Company Data

Medexus Pharmaceuticals Inc Ordinary Shares

Ticker
MEDXF
Current Price
$2.081 -1.54%
Market Cap
$51.3M
Price Target
Refer to Report
Volume
1.9K
52wk Range
$1.08 - $3.88
Advanced Market Data

Overview

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy